A股異動 | 川金諾漲6% 預計第三季度淨利同比增270%至300%
格隆匯10月11日丨川金諾(300505.SZ)漲5.55%,報39元,總市值53億元。川金諾10月10日發佈業績預吿,截止至2021年9月30日,公司預計第三季度淨利潤為5,728.41 萬元至6,192.88 萬元,同比增長270%到300%;而2021年前三季度預計淨利9025.69萬元-1億元,同比增長80%-100%。前三季度業績較上年同期增幅較大,主要原因是:上年同期受疫情影響,經營業績基數較小;今年市場逐步回暖,加之控股子公司廣西川金諾正常投運並表,使經營業績有較好釋放;但受國內疫情反覆、國家能耗雙控、產品原料價格上漲等因素影響,公司業績尚不及預期。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.